Clinical Trial Update: DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers [Phase 2]

View source ↗

Summary

Phase 2 study evaluating INO-3112 (DNA plasmid encoding interleukin-12 and HPV DNA plasmids) with Durvalumab in patients with recurrent or metastatic HPV-associ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Cervical Cancer
• Penile Cancer
• Vaginal Cancer
• Vulvar Cancer

Drugs mentioned

• Durvalumab (durvalumab)
• INO-3112 (DNA plasmid encoding interleukin-12 and HPV DNA plasmids)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Human Papillomavirus-16 Positive, Human Papillomavirus-18 Positive | Phase 2 | Status: TERMINATED | Results posted: 2024-07-09